Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Houston Healthspan Innovation Group is a Houston-based life sciences accelerator and company-building platform focused on regenerative medicine, immune restoration, and therapies for age-related disease. Rather than operating as a traditional single-asset biotech, the organization advises and supports early-stage biotech and life science companies through scientific, clinical, operational, financial, and commercialization capabilities. Its platform includes Houston Healthspan Bio Labs, which has been described as providing lab infrastructure, analytical testing, cleanrooms, cGMP cell culture workstations, bioprocessing support, and small-scale biologics manufacturing. The group has highlighted client and partner companies such as Rejenevie Therapeutics and Tissue Genesis, reflecting a focus on stem cell technologies, cell processing, and translational regenerative medicine. Overall, Houston Healthspan appears best characterized as a healthcare-focused accelerator/platform company rather than a developer of a proprietary in-house clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Houston Healthspan Innovation Group.